The strengthened mandate of the European Medicines Agency (EMA) came into full effect on 2 February. The last provisions of this mandate, Chapter IV of Regulation (EU) 2022/123, with the exception of Article 30, entered into force on 2 February.
At the same time, the Agency announced the upcoming establishment of a Medical Devices Shortages Steering Group (MDSSG).
Following the same model as the Steering Group on Shortages and Safety of Medicinal Products (MSSG) (see EUROPE B12952A8)...